Risperdal Injury Trial Leads to $70 Million Verdict Against Johnson & Johnson in Pennsylvania

Risperdal gynecomastia injuries and lawsuits

Law360 reports (subscription) that Johnson & Johnson received a $70 million verdict on a Philadelphia Risperdal injury case where side effectsd of the widely-prescribed antipsychotic drug caused an adolescent boy to grow prominent breasts. This verdict is significantly higher than other recent Pennsylvania Risperdal injury judgments against J&T over allegations that the drug caused breast growth. [Read more…]

First Risperdal Trial Ends With $2.5 Million Verdict Against J&J

First Risperdal Trial Ends With $2.5 Million Verdict Against J&J

A Philadelphia jury returned a $2.5 million verdict against healthcare giant Johnson & Johnson for a 20-year-old autistic man from Alabama who allegedly developed large breasts as a teenager while prescribed the antipsychotic medication Risperdal. The lawsuit charged that Johnson & Johnson failed to warn consumers of the distressing side effects that Risperdal causes, concealing from officials the dangerous and defective risks involved when taking the prescribed medication.

[Read more…]

Prescription Drug Risperdal Linked to Abnormal Male Breast Development

Attorney Wendy R. Fleishman of the national plaintiffs’ law firm Lieff Cabraser Heimann & Bernstein, LLP, announced that four young men prescribed the antipsychotic medication Risperdal recently filed separate personal injury lawsuits alleging that Risperdal is a defective and dangerous prescription drug. The complaints were brought against Johnson & Johnson and its subsidiary Janssen Pharmaceuticals, the manufacturer of Risperdal, in state court in Pennsylvania, where Janssen Pharmaceuticals is located. [Read more…]